Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination.

Duncan GJ, Manesh SB, Hilton BJ, Assinck P, Liu J, Moulson A, Plemel JR, Tetzlaff W.

Nat Commun. 2018 Aug 3;9(1):3066. doi: 10.1038/s41467-018-05473-1.

2.

Biochemically altered myelin triggers autoimmune demyelination.

Caprariello AV, Rogers JA, Morgan ML, Hoghooghi V, Plemel JR, Koebel A, Tsutsui S, Dunn JF, Kotra LP, Ousman SS, Wee Yong V, Stys PK.

Proc Natl Acad Sci U S A. 2018 May 22;115(21):5528-5533. doi: 10.1073/pnas.1721115115. Epub 2018 May 4.

3.

Deficient Surveillance and Phagocytic Activity of Myeloid Cells Within Demyelinated Lesions in Aging Mice Visualized by Ex Vivo Live Multiphoton Imaging.

Rawji KS, Kappen J, Tang W, Teo W, Plemel JR, Stys PK, Yong VW.

J Neurosci. 2018 Feb 21;38(8):1973-1988. doi: 10.1523/JNEUROSCI.2341-17.2018. Epub 2018 Jan 23.

4.

Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.

Micu I, Plemel JR, Caprariello AV, Nave KA, Stys PK.

Nat Rev Neurosci. 2017 Dec 14;19(1):58. doi: 10.1038/nrn.2017.166.

PMID:
29238086
5.

Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.

Micu I, Plemel JR, Caprariello AV, Nave KA, Stys PK.

Nat Rev Neurosci. 2018 Jan;19(1):49-58. doi: 10.1038/nrn.2017.128. Epub 2017 Nov 9. Review. Erratum in: Nat Rev Neurosci. 2017 Dec 14;19(1):58.

PMID:
29118449
6.

Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy.

Plemel JR, Michaels NJ, Weishaupt N, Caprariello AV, Keough MB, Rogers JA, Yukseloglu A, Lim J, Patel VV, Rawji KS, Jensen SK, Teo W, Heyne B, Whitehead SN, Stys PK, Yong VW.

Glia. 2018 Feb;66(2):327-347. doi: 10.1002/glia.23245. Epub 2017 Oct 25.

PMID:
29068088
7.

Myelinogenic Plasticity of Oligodendrocyte Precursor Cells following Spinal Cord Contusion Injury.

Assinck P, Duncan GJ, Plemel JR, Lee MJ, Stratton JA, Manesh SB, Liu J, Ramer LM, Kang SH, Bergles DE, Biernaskie J, Tetzlaff W.

J Neurosci. 2017 Sep 6;37(36):8635-8654. doi: 10.1523/JNEUROSCI.2409-16.2017. Epub 2017 Jul 31.

8.

Remyelination therapies: a new direction and challenge in multiple sclerosis.

Plemel JR, Liu WQ, Yong VW.

Nat Rev Drug Discov. 2017 Sep;16(9):617-634. doi: 10.1038/nrd.2017.115. Epub 2017 Jul 7. Review.

PMID:
28685761
9.

Myelin regulatory factor drives remyelination in multiple sclerosis.

Duncan GJ, Plemel JR, Assinck P, Manesh SB, Muir FGW, Hirata R, Berson M, Liu J, Wegner M, Emery B, Moore GRW, Tetzlaff W.

Acta Neuropathol. 2017 Sep;134(3):403-422. doi: 10.1007/s00401-017-1741-7. Epub 2017 Jun 19.

PMID:
28631093
10.

Cell transplantation therapy for spinal cord injury.

Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W.

Nat Neurosci. 2017 Apr 25;20(5):637-647. doi: 10.1038/nn.4541. Review.

PMID:
28440805
11.

Unique spectral signatures of the nucleic acid dye acridine orange can distinguish cell death by apoptosis and necroptosis.

Plemel JR, Caprariello AV, Keough MB, Henry TJ, Tsutsui S, Chu TH, Schenk GJ, Klaver R, Yong VW, Stys PK.

J Cell Biol. 2017 Apr 3;216(4):1163-1181. doi: 10.1083/jcb.201602028. Epub 2017 Mar 6.

12.

An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.

Keough MB, Rogers JA, Zhang P, Jensen SK, Stephenson EL, Chen T, Hurlbert MG, Lau LW, Rawji KS, Plemel JR, Koch M, Ling CC, Yong VW.

Nat Commun. 2016 Apr 26;7:11312. doi: 10.1038/ncomms11312.

13.

The molecular physiology of the axo-myelinic synapse.

Micu I, Plemel JR, Lachance C, Proft J, Jansen AJ, Cummins K, van Minnen J, Stys PK.

Exp Neurol. 2016 Feb;276:41-50. doi: 10.1016/j.expneurol.2015.10.006. Epub 2015 Oct 26.

PMID:
26515690
14.

Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.

Plemel JR, Juzwik CA, Benson CA, Monks M, Harris C, Ploughman M.

Mult Scler. 2015 Oct;21(12):1485-95. doi: 10.1177/1352458515601513. Epub 2015 Aug 18. Review.

PMID:
26286700
15.

Immune modulatory therapies for spinal cord injury--past, present and future.

Plemel JR, Wee Yong V, Stirling DP.

Exp Neurol. 2014 Aug;258:91-104. doi: 10.1016/j.expneurol.2014.01.025. Review.

PMID:
25017890
16.

Remyelination after spinal cord injury: is it a target for repair?

Plemel JR, Keough MB, Duncan GJ, Sparling JS, Yong VW, Stys PK, Tetzlaff W.

Prog Neurobiol. 2014 Jun;117:54-72. doi: 10.1016/j.pneurobio.2014.02.006. Epub 2014 Feb 28. Review.

PMID:
24582777
17.

Neutrophil contribution in facilitating optic nerve regeneration.

Singh B, Plemel JR.

J Neurosci. 2014 Jan 22;34(4):1081-2. doi: 10.1523/JNEUROSCI.4827-13.2014. No abstract available.

18.

Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.

Plemel JR, Manesh SB, Sparling JS, Tetzlaff W.

Glia. 2013 Sep;61(9):1471-87. doi: 10.1002/glia.22535. Epub 2013 Jul 10.

PMID:
23839973
19.

Motor axonal regeneration following cord transection.

Plemel JR, Cragg JJ.

J Neurosci. 2012 Nov 7;32(45):15645-6. doi: 10.1523/JNEUROSCI.3858-12.2012. No abstract available.

20.

Axonal thinning and extensive remyelination without chronic demyelination in spinal injured rats.

Powers BE, Lasiene J, Plemel JR, Shupe L, Perlmutter SI, Tetzlaff W, Horner PJ.

J Neurosci. 2012 Apr 11;32(15):5120-5. doi: 10.1523/JNEUROSCI.0002-12.2012.

Supplemental Content

Loading ...
Support Center